Friday, April 09, 2010

Inflammation


McAsey Enterprises | 785-341-4437
How does inflammation relate to heart disease and stroke risk?

“Inflammation” is the process by which the body responds to injury or an infection. Laboratory evidence and findings from clinical and population studies suggest that inflammation is important in atherosclerosis (ath”er-o-skleh-RO’sis). This is the process in which fatty deposits build up in the inner lining of arteries.

C-reactive protein (CRP) is one of the acute phase proteins that increase during systemic inflammation. It’s been suggested that testing CRP levels in the blood may be an additional way to assess cardiovascular disease risk. A more sensitive CRP test, called a highly sensitive C-reactive protein (hs-CRP) assay, is available to determine heart disease risk.

The American Heart Association and the Centers for Disease Control and Prevention published a joint scientific statement in 2003 on the use of inflammatory markers in clinical and public health practice. This statement was developed after systematically reviewing the evidence of association between inflammatory markers (mainly CRP) and coronary heart disease and stroke.

What’s the role of CRP in predicting recurrent cardiovascular and stroke events?

A growing number of studies have examined whether hs-CRP can predict recurrent cardiovascular disease, stroke and death in different settings. High levels of hs-CRP consistently predict recurrent coronary events in patients with unstable angina and acute myocardial infarction (heart attack). Higher hs-CRP levels also are associated with lower survival rates in these patients. Many studies have suggested that after adjusting for other prognostic factors, hs-CRP is useful as a risk predictor.

The Shaklee users who participated in The Landmark Supplement Study all had healthier levels of C-Reactive Protein.


VITALIZER
  -- CLICK Here


Matt
McAsey
785-341-4437

Shaklee Distributor
www.mcasey.myshaklee.com
The Business Concept Explained.....






You have been sent an eMail
If you cannot see the eMail please click here to view this mail in your web browser.


No comments: